Stock 300937 SICHUAN HEZONG MEDICINE EASY-TO-BUY PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.

Equities

300937

CNE100004CV9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
22.81 CNY -0.13% Intraday chart for Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. +2.66% -27.47%
Apr. 24 Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 10 Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co., Ltd. Proposes Final Dividend for 2023 CI

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co., Ltd. Proposes Final Dividend for 2023 CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Certain A Shares of Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 25-JAN-2024. CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Sichuan Zhonghuisheng Traditional Chinese Medicine Material partnership (limited partnership) agreed to acquire 80% stake in Sichuan Hezong Traditional Chinese Medicine Pieces Co., Ltd. from Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. for CNY 6.7 million. CI
Sichuan Hezong Medicine Co., Ltd. Announces Cash Dividend on A Shares for 2022, Payable 22 May 2023 CI
Sichuan Hezong Medicine Co., Ltd. Approves Cash Dividend for 2022 CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Hezong Medicine Easy-to-Buy Pharma to Apply For Up to 500 Million Yuan Bank Loan MT
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Li Yuemin agreed to acquire additional 58.02% stake in Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. from Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. for CNY 15.4 million. CI
Hezong Medicine Chairman Boosts Stake to 55% After 230 Million Yuan Deal MT
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co., Ltd. Announces Management Changes CI
Wuxu Data announced that it has received $0.3 million in funding from Sichuan Shenniao Century Technology Co., Ltd. and Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. and another investor CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Certain A Shares of Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 25-JAN-2022. CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Sichuan Hezong Medicine Easy to buy Pharmaceutical : to List 1.25% Stake as IPO Lockup Ends; Shares Slump 7% MT
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co., Ltd. Approves Cash Dividend for 2020 CI
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co., Ltd. Elelcts Liu Ran as Director CI

Chart Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.

Chart Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.
More charts

Company Profile

SICHUAN HZ-YEG MEDICAL Co Ltd is a China-based company mainly engaged in the pharmaceutical distribution industry. The Company mainly provides comprehensive medical circulation services in the out-of-hospital market. The Company's products cover western medicines, Chinese patent medicines, Chinese herbal medicines and Chinese medicinal materials, food and health food, medical equipment and non-medicinal products.
Sector
Pharmaceuticals
Calendar
2024-08-21 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
SICHUAN HEZONG MEDICINE EASY-TO-BUY PHARMACEUTICAL CO., LTD. Stock Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.
-27.47% 301M
MCKESSON CORPORATION Stock McKesson Corporation
+14.53% 69.68B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+7.11% 8.21B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.55% 7.96B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-4.06% 7.75B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+2.20% 4.64B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.32B
EBOS GROUP LIMITED Stock EBOS Group Limited
-1.24% 4.09B
GALENICA AG Stock Galenica AG
-3.37% 3.82B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+21.42% 3.62B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 300937 Stock
  4. News Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.
  5. Hezong Medicine Easy-to-Buy Pharma to Apply For Up to 500 Million Yuan Bank Loan